據報特斯拉(TSLA.US)人型機械人Optimus產量遠未達今年5,000部目標
《The Information》報道,特斯拉(TSLA.US)目前遠遠落後於創辦人馬斯克今年生產5,000部人型機械人Optimus的目標。
報道引述消息人士稱,今年至今Optimus產量僅數百部,並指馬斯克自離開白宮以來,與Optimus雙手相關的技術問題一直是其工作的重點,並稱Optimus要達到與人類雙手相同的靈活性和性能極其困難。
報道稱,特斯拉尚未能提高Optimus的產量,而特斯拉工廠裡仍然堆積一些缺少手部和前臂的Optimus機械人。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.